Log in
Get a demo
Product
Case Studies
Security
Team
Blog
Get a demo
Get a demo
Log in
Request Early Access
Sign up for Early Access of the DeepMirror App
Work Email
Organisation Type
Please select...
Industry
Academia
Where did you hear about us and what would you like to use the app for?
Submit
Request a Demo
Sign up for a demo of deepmirror
Work email
*
Organisation type
*
Select
Industry
Academia
Where did you hear about us and what would you like to use the app for?
Submit
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
deepmirror secures $2.4M to help chemists design drugs with one click
While AI could help chemists design optimal drug molecules faster, implementing it remained out of reach for most companies. deepmirror has raised $2.4M to simplify the adoption of AI for molecule design, enabling companies to get drugs to patients faster with their accessible AI-powered platform.
deepmirror
News
All
News
Case Study
Research
Learning
Use Case
deepmirror Obtains ISO27001 Certification
In drug discovery, where intellectual property and confidential data are paramount, ensuring robust security measures is a top priority...
Cecilia
News
6x faster discovery with deepmirror
How a European biotech used deepmirror to find novel scaffolds for first-in-class oncology drug candidates in just 2 weeks.
deepmirror
Case Study
One AI to rule them all?
Is there a single AI model that can accurately predict whether a molecule would be a good drug against a disease?
Cecilia
Research
deepmirror launches in Early Access
Innovative product enables medicinal chemists to access and integrate AI to boost productivity and creativity, to accelerate therapeutic drug discovery
Cecilia
News
deepmirror has been awarded an Innovate UK Biomedical Catalyst grant in collaboration with Nuclera
DeepMirror has successfully secured UKRI’s Biomedical Catalyst grant in collaboration with Nuclera.
Cecilia
News
Discovering potent and specific kinase inhibitors with the deepmirror App
Kinases are frequently dysregulated in disease and are an interesting yet challenging target against which to develop drugs. In this...
Cecilia
Use Case
deepmirror has been awarded a UKRI grant in collaboration with BiologIC
deepmirror has successfully secured UKRI’s Innovative technologies for nucleic acid medicines manufacturing grant in collaboration with BiologIC
Cecilia
News
deepmirror has been awarded the UK Global Incubator Programme Grant
DeepMirror has been selected as one of only 8 innovative companies to join the Global Incubator Programme for AI in the MaRS Discovery...
Cecilia
News
Drugging the undruggable with PROTACs
What are PROTACs? How do they work? How are PROTACs optimised?
Cecilia
Use Case
Previous
Next
1
...
2 / 3
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Stay in the loop!
We only send our newsletter every few months, so no inbox clutter.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Subscribe